Vanda Pharmaceuticals Inc.

Sleep-wake disorders

Clinical research includes Delayed Sleep-Wake Phase Disorder, Non-24 Hour Sleep-Wake Disorder, and insomnia disorder, with attention to circadian timing, sleep onset, and maintenance of regular sleep patterns.

  • Delayed Sleep-Wake Phase Disorder
  • Non-24 Hour Sleep-Wake Disorder
  • Insomnia disorder

The sponsor’s portfolio in this area centers on sleep regulation and the management of disrupted circadian rhythm alignment.

Gastrointestinal motility and nausea

Research activity also extends to idiopathic gastroparesis and diabetic gastroparesis, with a focus on persistent nausea and impaired gastric emptying.

  • Idiopathic gastroparesis
  • Diabetic gastroparesis
  • Moderate to severe nausea

This area reflects interest in upper gastrointestinal disorders associated with chronic symptom burden.

Pediatric sleep medicine

Trials include sleep-focused research in children, particularly pediatric insomnia, with outcomes tied to sleep timing and daily sleep behavior.

  • Pediatric insomnia
  • Sleep onset
  • Sleep diary assessment

The sponsor’s interest in this field covers age-specific sleep disruption and related functional effects.

Hematologic malignancies

Oncology research includes relapsed or refractory hematologic malignancies, indicating involvement in difficult-to-treat blood cancers.

  • Relapsed hematologic malignancies
  • Refractory hematologic malignancies
  • Blood cancer

This therapeutic area adds a cancer-focused dimension to the sponsor’s clinical portfolio.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study of tasimelteon compared to placebo for treating insomnia in children

    Recruiting

    1 1
    Investigated drugs:
    Germany Poland
  • Study on the Effects of Tasimelteon for Patients with Delayed Sleep-Wake Phase Disorder

    Recruiting

    1 1 1
    Investigated drugs:
    Austria Germany
  • Safety Study of Tasimelteon for Treating Non-24-Hour Sleep-Wake Disorder in Blind Individuals Without Light Perception

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    France
  • Safety Study of Tradipitant for Patients with Idiopathic or Diabetic Gastroparesis

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Germany